• Home
  • >
  • Sms Pharmaceuticals Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/sms-pharmaceuticals-ltd.png Logo

Sms Pharmaceuticals Ltd Financial Statement

Sms Pharmaceuticals Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue162.97167.45135.85
Operating Expense132.6138.82108.68
Net Profit12.1712.059.28
Net Profit Margin7.477.26.83
Earning Per Share1.441.421.1
EBIDTA30.1328.6226.69
Effective Tax Rate13.1710.8312.51

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Sms Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual522.05519.87563.18
Operating Expenses Annual467.55405.55442.07
Operating Profit Annual59.39119.53124.56
Interest Annual21.9218.8811.16
Depreciation30.7930.4920.89
Net Profit Annual-7.0662.2262.53
Tax Annual1.470.6230.16

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Sms Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning46.5840.429.54
Cash Flow from Operations22.4545.0690.45
Cash Flow from Investing-29.69-27.15-151.59
Cash Flow from Financing-31.97-11.7592.02
Cash Flow at the End7.3846.5840.42

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Sms Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)10.7221.5720.37
PBIT Margin (%)4.9315.7816.73
PBT Margin (%)4.7114.9615.24
Net PROFIT Margin (%)0.7412.259.97
Return On Networth / Equity (%)0.8315.4116.07
Return On Networth /Employed(%)3.7712.517.43
Return On Assets (%)0.569.6810.37
Total Debt / Equity(X)0.520.560.52
Asset Turnover Ratio (%)0.760.791.04

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Sms Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual412.02437.99457.36
Total Current Assets Annual410.65377.05309.33
Non Current Assets Annual468.96482.45502.88
Total Shareholders Funds Annual460.53470.29410.53
Total Assets Annual879.61859.5812.21

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Sms Pharmaceuticals Ltd Earning Calls
Dec 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Sms Pharmaceuticals Ltd has a market capitalization of 489.29 Cr. Value Research classifies it as a Small-Cap company.

No, Sms Pharmaceuticals Ltd is not debt-free with a debt-to-equity ratio of 0.55.

In FY 2023, Sms Pharmaceuticals Ltd recorded a total revenue of approximately 522.05 Cr marking a significant milestone in the company's financial performance.

Sms Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.4% and -0.0% annually, respectively..

Sms Pharmaceuticals Ltd's current PE ratio is -69.30.

Sms Pharmaceuticals Ltd's ROCE averaged 10.4% from the FY ending March 2021 to 2023, with a median of 11.9%. It peaked at 15.4% in March 2021, reflecting strong capital efficiency over the period..

Sms Pharmaceuticals Ltd's latest EBIT is Rs. 27.26 Cr, surpassing the average EBIT of Rs. 72.31 Cr over the 5 years..